FIDE Grand Swiss 2025:Vaishali Rameshbabu has won the FIDE Grand Swiss tournament for the second time in two editions after drawing her final game against former women’s world champion Tan Zhongyi on ...
Gukesh vs Divya Deshmukh FIDE Grand Swiss 2025 Chess Round 8 Highlights: World champion Gukesh Dommaraju was held to a draw by Divya Deshmukh after a six-hour marathon game that involved 103 moves in ...
BERLIN – On paper, Germany is set to sign its first-ever bilateral friendship treaty with the UK on Thursday. In reality, it’s just one side of a bigger structure. German government officials have ...
At first glance the mid-range rangefinder-style mirrorless Fujifilm XE5 that was launched in 2025 and the XE4 from 2021 look quite similar, but there are some important differences between them in ...
When the Fujifilm X-E4 launched in 2021, the compact mirrorless camera was clearly a budget choice, sitting even under the X-S10 at $949 / £799 / AU$1,399 body only or $1,049 / £949 / AU$1,799 bundled ...
In any chess game there is an opening, a middle game and an ending. Some games, especially for beginners, do not go through the three stages, but as your play improves it becomes necessary to learn ...
With the Fujifilm X-E4's similarities to the X100VI, I think an updated X-E5 could be a trendy camera When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...
He didn’t exactly have Paul Morphy’s number, but largely unheralded 19th century English master Thomas Barnes — born 200 years ago this month — did manage to win more chess games off the brilliant ...
Chess solution 2662 1 Bxg4! Qxg4 2 d5! wins a piece and the game for White. If 2....exd5? 3 Nd6+ and 4 Qxg4. Chess solution 2661 1 Rg8+! Rxg8 2 Qa1+! Re5 3 Qxe5+ Qf6 4 Qxf6+ Rg7 5 Qxg7 mate. Chess ...
Yakuza Kiwami includes several collectibles known as Locker Keys that can be found all over the district of Kamurocho. They can be spotted by the faint shining dot on the ground, and unlock a series ...
Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma in early-phase studies. In a phase 3, multicenter, open-label, active-controlled trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results